⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 14, 2024SynfactsOpen Access

Using Artificial Intelligence to Identify TRAF2- and NCK-Interacting Kinase as a Target for Fibrosis

Antonia F. Stepan Nicholas A. Meanwell

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Key words artificial intelligence - TRAF2- and NCK-interacting kinase inhibitor - anti-fibrotic activity

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Stepan et al. (2024) studied this question.

synapsesocial.com/papers/68e64c3ab6db6435875dc777 https://doi.org/10.1055/s-0043-1774881

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models2024 · 348 citations
2Traf2- and Nck-interacting kinase inhibitors: a patent review（2008 – 2024）2025 · 1 citations
3AI-based Predictive Signaling Pathway Profiling in Cardiac Fibrosis Suggests a Novel Combinatorial Treatment Strategypreclinical · 2025
4Integrated Machine Learning and Structure-Based Virtual Screening Identify Osimertinib as a TNIK Inhibitor for Idiopathic Pulmonary Fibrosis2025 · 4 citations
5B77-22 Mesenchymal Targeted Therapeutics for Selectively Modulating Kinase Signaling in Pulmonary FibrosisClinical Trial · 2026

Insilico reveals a ‘soup to nuts’ process for AI-generated lung fibrosis drug2024
Axitinib targets cardiac fibrosis in pressure overload-induced heart failure through VEGFA-KDR pathway2023
NGF-TRKA Facilitates the Activation of Lung Fibroblasts and Modulates the Immune Response in Pulmonary Fibrosis Via the FAK/ERK Signaling Pathway2026
Asymmetric [4+2] Photocycloaddition of Aminoquinolines with Styrenes to TetrahydroquinolinesSynfacts · 2026
Electrocatalytic Synthesis of cis-Aziridines via Cobalt CatalysisSynfacts · 2026

More from Synfacts